25.01.2013 Views

Cancer Immune Therapy Edited by G. Stuhler and P. Walden ...

Cancer Immune Therapy Edited by G. Stuhler and P. Walden ...

Cancer Immune Therapy Edited by G. Stuhler and P. Walden ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

390 Glossary<br />

cytes <strong>and</strong> addressing leukocytes. There are now, however, reports of ILs produced <strong>by</strong><br />

other cells as well, such as IL-10 <strong>by</strong> keratinocytes, of ILs having a broad range of effects<br />

on non-leukocytes <strong>and</strong> of cell surface variants of some of the ILs, such as IL-1.<br />

Among the ILs which are particularly important in the context of tumor immunology<br />

<strong>and</strong> cancer immunotherapy are IL-2 as a growth <strong>and</strong> differentiation factor for<br />

T lymphocytes, IL-4 <strong>and</strong> IL-6 as factors regulating B lymphocyte differentiation, IL-10<br />

as an immune-suppressive factor, <strong>and</strong> IL-12 which is thought to be particularly potent<br />

in supporting immune responses <strong>by</strong> CD8 + effector T lymphocytes.<br />

Lymphokine-activated killer (LAK) cell<br />

Lymphocytic cell generated in the absence of antigen <strong>by</strong> exposure to high doses of cytokines<br />

such as interleukin-2 exhibiting a high cytolytic capacity. LAK activity is perforin/granzyme<br />

dependent <strong>and</strong> not antigen specific. Natural killer cells are a major<br />

source for LAK cells.<br />

Major histocompatibility complex (MHC)<br />

Gene complex that controls the rapid rejection of MHC-disparate transplants ±<br />

hence its name. The MHC genes are highly polymorphic <strong>and</strong> map in humans [human<br />

leukocyte antigens (HLA)] to the short arm of chromosome 6 <strong>and</strong> in mice (H-2)<br />

to chromosome 17. Their gene products fall into two functionally <strong>and</strong> structurally<br />

distinct classes: MHC class I molecules (HLA-A, -B, <strong>and</strong> -C in humans or H-2K, -D<br />

<strong>and</strong> -C in mice) are heterodimers of the polymorphic transmembrane heavy chain<br />

<strong>and</strong> the non-covalently associated non-polymorphic b2-microglobulin. They bind <strong>and</strong><br />

present peptides that are usually 8±10 amino acids for recognition <strong>by</strong> CD8 + T lymphocytes.<br />

MHC class II molecules (HLA-DP, -DQ <strong>and</strong> DR in humans, <strong>and</strong> H-2A <strong>and</strong><br />

H-2E in mice) consist of two polymorphic non-covalently associated transmembrane<br />

polypeptides. They bind <strong>and</strong> present peptides of 11 or more amino acids for recognition<br />

<strong>by</strong> CD4 + T lymphocytes. MHC class I molecules are expressed <strong>by</strong> most nucleated<br />

cells; MHC class II molecules, however, are expressed only <strong>by</strong> antigen-presenting<br />

cells <strong>and</strong> stimulated epithelial cells. In addition to MHC class I molecules, the<br />

MHC also encodes for the MHC class Ib molecules HLA-E, -F <strong>and</strong> -G, which resemble<br />

MHC class I molecules in their structure but exhibit a limited polymorphism<br />

<strong>and</strong> serve a range of different functions including the presentation of N-formylated<br />

peptides <strong>and</strong> lipids or, independent of any antigen presentation, as inhibitory receptors<br />

for natural killer cells.<br />

Monocyte<br />

Mononuclear cell that circulate in the blood, emigrate into tissues <strong>and</strong> differentiate<br />

into phagocytic macrophages. Monocytes are a main source of dendritic cells of the<br />

myeloid type that are used in many protocols for cancer immune therapy.<br />

Natural killer (NK) cell<br />

Large, lymphocyte-like cell with characteristic granula that play a role in natural resistance<br />

to tumors <strong>and</strong> in antibody-dependent cellular cytotoxicity. NK cells variably<br />

express killer cell immunoglobulin-like receptors (KIRs) <strong>and</strong> CD94/NKG2 that trans-

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!